bluebird bio Inc (NASDAQ:BLUE)

8.09
BATS BZX Real-Time Price
As of 1:35pm ET
 +0.33 / +4.25%
Today’s Change
6.75
Today|||52-Week Range
31.67
-19.02%
Year-to-Date
Is a Beat in Store for HCA Healthcare's (HCA) Q4 Earnings?
Jan 24 / Zacks.com - Paid Partner Content
bluebird (BLUE) Gene Therapies BLA Decision Delayed, Stock Down
Jan 19 / Zacks.com - Paid Partner Content
Anthem (ANTM) Gears Up for Q4 Earnings: What's in the Cards?
Jan 21 / Zacks.com - Paid Partner Content
Why Bluebird Bio Stock Is Sinking This Week
Jan 14 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: ZGNX's Acquisition News, REGN, BLUE's Updates & More
Jan 20 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close7.76
Today’s open7.91
Day’s range7.69 - 8.14
Volume42,205
Average volume (3 months)2,011,025
Market cap$509.0M
Data as of 1:35pm ET, 01/26/2022

Growth & Valuation

Earnings growth (last year)+30.45%
Earnings growth (this year)-80.12%
Earnings growth (next 5 years)-64.66%
Revenue growth (last year)+461.25%
P/E ratioNM
Price/Sales10.73
Price/Book0.36

Competitors

 Today’s
change
Today’s
% change
PSNLPersonalis Inc+0.87+8.39%
VXRTVaxart Inc+0.21+4.46%
BNGOBionano Genomics Inc+0.10+4.89%
DCPHDeciphera Pharmaceut...+0.26+3.07%
Data as of 1:36pm ET, 01/26/2022

Financials

Next reporting dateFebruary 23, 2022
EPS forecast (this quarter)-$1.97
Annual revenue (last year)$250.7M
Annual profit (last year)-$618.7M
Net profit margin-246.75%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts